BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

619 related articles for article (PubMed ID: 27779700)

  • 1. Decreased expression of long non-coding RNA GAS5 promotes cell proliferation, migration and invasion, and indicates a poor prognosis in ovarian cancer.
    Li J; Huang H; Li Y; Li L; Hou W; You Z
    Oncol Rep; 2016 Dec; 36(6):3241-3250. PubMed ID: 27779700
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Decreased expression of long noncoding RNA GAS5 indicates a poor prognosis and promotes cell proliferation in gastric cancer.
    Sun M; Jin FY; Xia R; Kong R; Li JH; Xu TP; Liu YW; Zhang EB; Liu XH; De W
    BMC Cancer; 2014 May; 14():319. PubMed ID: 24884417
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Decreased expression of lncRNA GAS5 predicts a poor prognosis in cervical cancer.
    Cao S; Liu W; Li F; Zhao W; Qin C
    Int J Clin Exp Pathol; 2014; 7(10):6776-83. PubMed ID: 25400758
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long non-coding RNA growth arrest-specific transcript 5 is involved in ovarian cancer cell apoptosis through the mitochondria-mediated apoptosis pathway.
    Gao J; Liu M; Zou Y; Mao M; Shen T; Zhang C; Song S; Sun M; Zhang S; Wang B; Zhu D; Li P
    Oncol Rep; 2015 Dec; 34(6):3212-21. PubMed ID: 26503132
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognostic and predictive value of long non-coding RNA GAS5 and mircoRNA-221 in colorectal cancer and their effects on colorectal cancer cell proliferation, migration and invasion.
    Liu L; Meng T; Yang XH; Sayim P; Lei C; Jin B; Ge L; Wang HJ
    Cancer Biomark; 2018; 22(2):283-299. PubMed ID: 29630521
    [TBL] [Abstract][Full Text] [Related]  

  • 6. LncRNA GAS5 suppresses the tumorigenesis of cervical cancer by downregulating miR-196a and miR-205.
    Yang W; Hong L; Xu X; Wang Q; Huang J; Jiang L
    Tumour Biol; 2017 Jul; 39(7):1010428317711315. PubMed ID: 28671039
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lowly-expressed lncRNA GAS5 facilitates progression of ovarian cancer through targeting miR-196-5p and thereby regulating HOXA5.
    Zhao H; Yu H; Zheng J; Ning N; Tang F; Yang Y; Wang Y
    Gynecol Oncol; 2018 Nov; 151(2):345-355. PubMed ID: 30201235
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long non-coding RNA PVT1 promotes cell proliferation and invasion through regulating miR-133a in ovarian cancer.
    Yang Q; Yu Y; Sun Z; Pan Y
    Biomed Pharmacother; 2018 Oct; 106():61-67. PubMed ID: 29957467
    [TBL] [Abstract][Full Text] [Related]  

  • 9. NFATc1 regulates cell proliferation, migration, and invasion of ovarian cancer SKOV3 cells in vitro and in vivo.
    Li L; Duan Z; Yu J; Dang HX
    Oncol Rep; 2016 Aug; 36(2):918-28. PubMed ID: 27350254
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A long noncoding RNA AB073614 promotes tumorigenesis and predicts poor prognosis in ovarian cancer.
    Cheng Z; Guo J; Chen L; Luo N; Yang W; Qu X
    Oncotarget; 2015 Sep; 6(28):25381-9. PubMed ID: 26299803
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The long non-coding RNA CCAT2 is up-regulated in ovarian cancer and associated with poor prognosis.
    Huang S; Qing C; Huang Z; Zhu Y
    Diagn Pathol; 2016 Jun; 11(1):49. PubMed ID: 27283598
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The long non-coding RNA, GAS5, enhances gefitinib-induced cell death in innate EGFR tyrosine kinase inhibitor-resistant lung adenocarcinoma cells with wide-type EGFR via downregulation of the IGF-1R expression.
    Dong S; Qu X; Li W; Zhong X; Li P; Yang S; Chen X; Shao M; Zhang L
    J Hematol Oncol; 2015 Apr; 8():43. PubMed ID: 25925741
    [TBL] [Abstract][Full Text] [Related]  

  • 13. LncRNA GAS5 inhibits the proliferation and invasion of ovarian clear cell carcinoma via the miR-31-5p/ARID1A axis.
    Zhang J; Yang ZM; Huang Y; Wang KN; Xie Y; Yang N
    Kaohsiung J Med Sci; 2021 Nov; 37(11):940-950. PubMed ID: 34414664
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Upregulation of Long Noncoding RNA_GAS5 Suppresses Cell Proliferation and Metastasis in Laryngeal Cancer via Regulating PI3K/AKT/mTOR Signaling Pathway.
    Liu W; Zhan J; Zhong R; Li R; Sheng X; Xu M; Lu Z; Zhang S
    Technol Cancer Res Treat; 2021; 20():1533033821990074. PubMed ID: 33641529
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Decreased expression of long non-coding RNA GAS5 indicates a poor prognosis and promotes cell proliferation and invasion in hepatocellular carcinoma by regulating vimentin.
    Chang L; Li C; Lan T; Wu L; Yuan Y; Liu Q; Liu Z
    Mol Med Rep; 2016 Feb; 13(2):1541-50. PubMed ID: 26707238
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Downregulation of LncRNA-RP11-317J10.2 promotes cell proliferation and invasion and predicts poor prognosis in colorectal cancer.
    Luo J; Xu LN; Zhang SJ; Jiang YG; Zhuo DX; Wu LH; Jiang X; Huang Y
    Scand J Gastroenterol; 2018 Jan; 53(1):38-45. PubMed ID: 29073791
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A critical role for the long non-coding RNA GAS5 in proliferation and apoptosis in non-small-cell lung cancer.
    Shi X; Sun M; Liu H; Yao Y; Kong R; Chen F; Song Y
    Mol Carcinog; 2015 Jun; 54 Suppl 1():E1-E12. PubMed ID: 24357161
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The high expression of long non-coding RNA PANDAR indicates a poor prognosis for colorectal cancer and promotes metastasis by EMT pathway.
    Lu M; Liu Z; Li B; Wang G; Li D; Zhu Y
    J Cancer Res Clin Oncol; 2017 Jan; 143(1):71-81. PubMed ID: 27629879
    [TBL] [Abstract][Full Text] [Related]  

  • 19. LncRNA GAS5 regulates the proliferation, migration, invasion and apoptosis of brain glioma cells through targeting GSTM3 expression. The effect of LncRNA GAS5 on glioma cells.
    Li G; Cai Y; Wang C; Huang M; Chen J
    J Neurooncol; 2019 Jul; 143(3):525-536. PubMed ID: 31172354
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long noncoding RNA-JPX predicts the poor prognosis of ovarian cancer patients and promotes tumor cell proliferation, invasion and migration by the PI3K/Akt/mTOR signaling pathway.
    Li J; Feng L; Tian C; Tang YL; Tang Y; Hu FQ
    Eur Rev Med Pharmacol Sci; 2018 Dec; 22(23):8135-8144. PubMed ID: 30556851
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 31.